Guobang Pharma Ltd Cash Flow Reinvestment Rate
Guobang Pharma Ltd cash flow reinvestment rate. Guobang Pharma Ltd (605507) has a Cash Flow Reinvestment Rate of 0.36x as of September 2025, reinvesting CN¥110.58 Million (capex CN¥110.58 Million ) from operating cash flow of CN¥311.27 Million. Explore Guobang Pharma Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Guobang Pharma Ltd (2017–2025)
Cash flow reinvestment rate of Guobang Pharma Ltd from 2017 to 2025. Historical reinvestment intensity for Guobang Pharma Ltd across 8 annual periods. Explore Guobang Pharma Ltd (605507) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Guobang Pharma Ltd Cash Flow Reinvestment Rate by Year (2017–2025)
Guobang Pharma Ltd cash flow reinvestment rate by year from 2017 to 2025. Year-by-year capital reinvestment analysis for Guobang Pharma Ltd. For the full cash flow conversion analysis, see 605507 operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.57x | CN¥875.56 Million | CN¥559.28 Million | CN¥277.71 Million | ▲ +108.0% |
| 2024 | 0.75x | CN¥531.80 Million | CN¥706.41 Million | CN¥419.12 Million | ▼ -64.9% |
| 2023 | 2.15x | CN¥1.11 Billion | CN¥516.76 Million | CN¥748.44 Million | ▲ +79.8% |
| 2022 | 1.19x | CN¥1.21 Billion | CN¥1.02 Billion | CN¥803.12 Million | ▲ +3.6% |
| 2020 | 1.15x | CN¥885.39 Million | CN¥767.70 Million | CN¥520.16 Million | ▼ -44.3% |
| 2019 | 2.07x | CN¥912.52 Million | CN¥440.86 Million | CN¥605.18 Million | ▲ +586.8% |
| 2018 | 0.30x | CN¥163.24 Million | CN¥541.68 Million | CN¥163.24 Million | ▼ -73.7% |
| 2017 | 1.14x | CN¥169.48 Million | CN¥148.03 Million | CN¥169.48 Million | — |